IN8bio is accelerating patient enrollment in the INB-100 program and expects to complete enrollment of the expansion cohort in 2025. The company's FDA discussions confirmed that relapse-free survival ...

Investors know the biotech industry is a waiting game—smaller companies in this space often work to secure the funding to ...

Vistagen Therapeutics, Inc.'s fasedienol shows promise in treating social anxiety; new results expected 2025. Click for my ...

U.S.-based PleoPharma announced yesterday that the FDA has granted it a fast-track designation for PP-01, a new ...

Captain America: Brave New World marks the penultimate movie release of Phase 5 of the MCU which marks the midway point of The Multiverse Saga. This year sees the release of two other MCU movies ...